
Big Pharma Issues Industry Roadmap On Antimicrobial Resistance
Major pharmaceutical companies today issued a roadmap they said aims to bring solutions to the problem of antimicrobial resistance (AMR). The plan, issued on the eve of the United Nations General Assembly High-Level Meeting on Antimicrobial Resistance, targets environmental impact, use of antibiotics only by those who need them, improved access to medical products, and public-private partnerships.









